News and Trends 22 Jan 2018 Abcam Will Start Selling Over 700 Antibodies from Roche Abcam and Roche have entered an agreement that will let Abcam sell 760 new antibodies to researchers worldwide through its online platform. Inspired by Amazon, Abcam has become one of Europe’s biggest biotechs by building a platform to make it easier for researchers to order the antibodies they need for their experiments. A new deal with […] January 22, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 22 Jan 2018 No More Mosquito Bites? Targeting These Genes Could Prevent Future Outbreaks! Researchers may have found a way to stop the female mosquitoes from biting you, which could help to prevent the spread of diseases like malaria. Scientists at the University of Birmingham in the UK and the University of Notre Dame in Paris, along with collaborators in the US, have identified 902 genes specific to blood-feeding mosquitoes […] January 22, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 19 Jan 2018 The European Patent Office Revokes the Broad Institute‘s CRISPR Patents The Broad Institute has been dealt a big blow in its battle for CRISPR/Cas9 intellectual property, with the European Patent Office revoking one of its patents. CRISPR/Cas9 has been hailed as the ‘scientific discovery of the century’ due to its capacity to modify the genome for the treatment of genetic diseases. The Broad Institute, set up by MIT […] January 19, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jan 2018 France Gets Ready to Test CAR-Treg Cells to Avoid Transplant Rejection TxCell has received a €1.2 loan from Bpifrance to complete preclinical trials with its CAR-Treg technology for transplant rejection and start human testing. French biotech TxCell is finalizing the preparations to take its first cell therapy to clinical trials. The treatment, called HLA-A2 CAR-Treg, is intended for the prevention of chronic rejection after organ transplantation. […] January 18, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jan 2018 Meet the 10 Promising Synbio Startups in RebelBio’s London Cohort Irish accelerator RebelBio has launched its latest cohort of startups that will receive its support during a 3-month program at Imperial College London. RebelBio is a startup accelerator that helps entrepreneurs to build technology associated with the life sciences field. It offers seed funding, lab space, mentorship, and a community of successful and diverse founders […] January 18, 2018 - 4 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jan 2018 This Cytokine is Key to Autoimmune and Inflammatory Diseases An international group of researchers has found that the cytokine IL-23 is heavily involved in autoimmune and inflammatory diseases, opening the door to new therapies targeting the molecule. Research at the VIB-UGent Center for Inflammation Research has identified a crucial molecular mechanism underlying autoimmune and inflammatory diseases like psoriasis, rheumatoid arthritis, and multiple sclerosis. The study, […] January 18, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 18 Jan 2018 Report from JP Morgan 2018: Taking the Financial Temperature of Biotech As heard at JP Morgan 2018, last year was an ok year for biotech. But how does 2018 look? Here are the thoughts of a panel convened to discuss the numbers. A biotech whirlwind swept through San Francisco last week as the industry descended on Union Square for the JP Morgan Healthcare Conference of 2018. […] January 18, 2018 - 5 minutesmins - By Evelyn Warner Share WhatsApp Twitter Linkedin Email
News and Trends 17 Jan 2018 French Biotech Closes a €18.5M Series B to Boost Colon Cancer Diagnostics HalioDx hopes that its Immunoscore diagnostics platform can help to provide precision medicine for a number of indications, including colon cancer. HalioDx is an expert in cancer diagnostics, specializing in the analysis of the tumor microenvironment. The company has closed a €18.5M Series B financing round – impressive considering the concerns over reimbursement that investors often have for diagnostic […] January 17, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 17 Jan 2018 Here’s Your New Year’s Resolution: Get Your Immune System in Shape If you’re having trouble deciding on a New Year’s resolution, why not train up your immune system? Scientists believe this could help prevent the side effects of chemotherapy. Researchers at Technische Universitaet Dresden believe that by ‘training’ the immune system, cancer patients undergoing chemotherapy could be spared some of the trauma. The study, published in Cell, […] January 17, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jan 2018 Oxford Firm Recruits Two Partners to Build Drug Discovery AI e-Therapeutics has teamed up with AI experts Intellegens and Biorelate to improve its technology for computer-based drug discovery. Based in Oxford, e-Therapeutics has the mission of reducing the time and money it costs to develop new drugs with the help of artificial intelligence. Its platform can explore large amounts of public and private databases to […] January 16, 2018 - 1 minutemin - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jan 2018 This French Biotech’s Medical Device Protects Against Antibiotic Resistance Da Volterra has achieved impressive early results with its antibiotic resistance-busting medical device by successfully protecting the diversity of the microbiome. French biotech Da Volterra is developing products to fight the rapidly rising rates of antibiotic resistance. During a Phase I study, the company’s medical device, DAV132, was used with the antibiotic, moxifloxacin, and successfully protected the intestinal […] January 16, 2018 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 16 Jan 2018 Dutch Biotech Joins International Effort to Eradicate Polio Batavia Biosciences joins an international consortium to develop and manufacture a safer type of polio vaccine. Their ultimate goal is to eradicate the disease. Based in Leiden, the Netherlands, Batavia Biosciences specializes in the development and production of viruses and proteins. Its expertise has attracted an international consortium to recruit Batavia in their effort to […] January 16, 2018 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email